Elsevier

Differentiation

Volume 73, Issue 5, June 2005, Pages 249-260
Differentiation

ORIGINAL ARTICLE
Characterization of cells in the developing human liver

https://doi.org/10.1111/j.1432-0436.2005.00019.xGet rights and content

Abstract

Human hepatic progenitor cells (HPCs) have been shown to co-express the hematopoietic stem cell (HSC) markers, CD117 and CD34. These cells differentiate not only into hepatocytes and cholangiocytes but also into pancreatic ductal and acinar cells under certain conditions. The fetal liver (FL) is rich in precursor/stem cells; however, little is known about (i) the markers expressed by liver cells during fetal development and (ii) whether an equivalent to the adult liver stem-like progenitors exists in the FL. Here, (i) FL tissue obtained from human 5–18-week-old fetuses were evaluated by means of flow cytometry, immunocyto-, and histochemistry for the emergence of cells expressing and co-expressing known hematopoietic, hepatic, and pancreatic cell markers, and (ii) isolated putative HPCs were phenotypically and molecularly characterized. We report that (i) red blood and endothelial cell precursors were most abundant in early gestation. Cells expressing HSC and pancreatic markers were found in the first trimester, while cells expressing hepatic markers appeared in the second trimester. Very few committed cells were present in FLs obtained early in the first trimester. In addition, cells expressing pancreatic markers co-expressed the HSC marker CD117. (ii) Isolated CD117+/CD34+/CD90− cells in vitro expressed both the genes and proteins for the hepatic markers such as albumin, alpha feto protein (AFP), α1-antitrypsin, and cytokeratin 19 (CK19).

Our study suggests that hepatoblast and ductal plate/bile duct development mainly occurs during the second trimester. FLs in gestation weeks 5–9 had the highest numbers of precursor cells and the least committed cells. Cells that differentiate into Alb+ or CK19+ can be isolated from early FLs and may be appropriate progenitors for establishing novel systems to investigate basic mechanisms for cell therapy.

References (35)

  • M.J. Sánchez et al.

    Characterization of the first definitive hematopoietic stem cells in the AGM and liver of the mouse embryo

    Immunity

    (1996)
  • M.R. Alison et al.

    Hepatocytes from non-hepatic adult stem cells

    Nature

    (2000)
  • X. Bo et al.

    Chronic exposure to tumor necrosis factor in vivo alters the function of liver T lymphocytes in patients with primary sclerosing cholangitis

    Gut

    (2001)
  • X. Bo et al.

    Capillarization of hepatic sinusoid by liver endothelial cell-reactive autoantibodies in patients with cirrhosis and chronic hepatitis

    Am J Pathol

    (2003)
  • M.D. Dabeva et al.

    Differentiation of pancreatic epithelial progenitor cells into hepatocytes following transplantation into rat liver

    Proc Natl Acad Sci USA

    (1997)
  • G. Deutsch et al.

    A bipotential precursor population for pancreas and liver within the embryonic endoderm

    Development

    (2001)
  • W.M. Elliot et al.

    Development of the adult endocrine pancreas during metamorphosis in the sea lamprey, Petromyzon marinus L. II. Electron microscopy and immunocytochemistry

    Anat Rec

    (1993)
  • Cited by (78)

    • Functional Blood Progenitor Markers in Developing Human Liver Progenitors

      2016, Stem Cell Reports
      Citation Excerpt :

      Co-expressions of CD117 and AFP or CD117 and ALB in hepatoblasts are detected at around 14 weeks and represent about 2% and 1% of total cells, respectively (Nava et al., 2005). A subset of CD117+ cells that co-express CD34 can turn on the hepatic markers ALB and CK19 when further cultured in vitro suggesting the presence of CD177+CD34+ precursors of hepatoblasts (Nava et al., 2005; Nowak et al., 2005). Similarly, human fetal liver multipotent progenitor cells have been identified from fetal livers from first and second trimesters (Lazaro et al., 2003); they express CD34 and CD44 and differentiate into ALB+glycogen+ hepatoblasts, CK7+GGT+CK19+ biliary cells, and mesenchymal cells (Dan et al., 2006).

    • Hepatitis B viral infection of hepatic progenitor cells. Resolving unresolved questions?

      2016, Medical Hypotheses
      Citation Excerpt :

      HBV infection of hepatic progenitor cells (HPCs) within the newborn liver is responsible for the chronic HBV that occurs in this age group. Whereas HPCs constitute only a small percent (<1%) of the adult liver cell population, in newborns their prevalence is as high as 10–15% [11,12]. Moreover, essentially all of the HPCs are sufficiently differentiated (i.e. at the “hepatoblast” stage) to express the sodium taurocholate receptor required for HBV entry into cells.

    View all citing articles on Scopus
    View full text